Enliven Therapeutics Inc. (ELVN) — Financial Flexibility Index
Enliven Therapeutics Inc. (ELVN) has a Financial Flexibility Index of -1.68x as of March 2026. Free cash flow of $-19.29 Million (operating CF $-19.29 Million minus capex $0.00) represents -2% of total liabilities ($11.49 Million). Also explore ELVN year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Enliven Therapeutics Inc. Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Enliven Therapeutics Inc. across 9 annual periods. Check how strategically is Enliven Therapeutics Inc.'s equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Enliven Therapeutics Inc. (2017–2025)
Year-by-year free cash flow to debt coverage for Enliven Therapeutics Inc.. For the full company profile including market capitalisation, see Enliven Therapeutics Inc. stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.21x | $-70.14 Million | $-70.30 Million | $16.68 Million | ▲ +8.5% |
| 2024 | -4.60x | $-73.15 Million | $-73.19 Million | $15.91 Million | ▼ -95.2% |
| 2023 | -2.35x | $-61.12 Million | $-61.27 Million | $25.96 Million | ▼ -1098.1% |
| 2022 | -0.20x | $-31.46 Million | $-32.08 Million | $160.12 Million | ▲ +93.3% |
| 2021 | -2.93x | $-18.94 Million | $-19.13 Million | $6.47 Million | ▼ -132.6% |
| 2020 | -1.26x | $-8.07 Million | $-8.53 Million | $6.41 Million | ▲ +74.6% |
| 2019 | -4.96x | $-21.74 Million | $-21.88 Million | $4.38 Million | ▼ -3.5% |
| 2018 | -4.79x | $-8.78 Million | $-8.78 Million | $1.83 Million | ▲ +19.0% |
| 2017 | -5.91x | $-8.79 Million | $-8.79 Million | $1.49 Million | — |